摘要
目的对锦葵科蜀葵属植物药蜀葵Althaea officinalis茎叶的化学成分及其体外抑制α-葡萄糖苷酶和5-脂氧合酶活性进行研究。方法运用D101大孔吸附树脂、硅胶柱、MCI凝胶、Sephadex LH-20以及半制备HPLC等多种色谱方法进行分离纯化,根据波谱数据鉴定化合物的结构;通过测定化合物对α-葡萄糖苷酶和5-脂氧合酶体外抑制活性,评价化合物的降血糖和抗炎作用。结果从药蜀葵茎叶中共分离得到24个化合物,分别鉴定为腺苷(1)、4-羟基-2,6二甲氧基苯基-β-D-吡喃葡萄糖苷(2)、苄基-O-β-D-吡喃葡萄糖苷(3)、赤藓醇(4)、5-羟甲基-2-呋喃甲醛(5)、1-[5-(hydroxymethyl)furan-2-yl]ethenone(6)、黑麦草内酯(7)、isololiolide(8)、4-羟基苯甲醛(9)、对羟基苯甲酸甲酯(10)、催吐萝芙木醇(11)、(6S,7Z,9R)-roseoside(12)、二氢芥子醇(13)、3-(3,4,5-trimethoxyphenyl)propan-1-ol(14)、dihydrodehydrodiconifenyl alcohol(15)、齐墩果酸3-O-β-D-吡喃葡萄糖苷(16)、紫云英苷(17)、反式银椴苷(18)、望春花黄酮醇苷(19)、apigenin7-O-(6’’-trans-p-coumaroyl-β-D-glucopyranoside)(20)、香叶木素7-O-β-D-吡喃葡萄糖苷(21)、田蓟苷(22)、芒柄花素7-葡萄糖苷(23)、acacetin 7-O-(6’’-p-coumaroyl)-β-D-glucopyranoside(24)。生物活性测试结果表明,化合物18、19、24对α-葡萄糖苷酶半数抑制浓度(median inhibition concentration,IC_(50))为(12.2±1.3)、(2.8±0.6)、(31.1±3.9)μmol/L;化合物18、24对5-脂氧合酶的IC50为(34.76±4.3)、(25.37±2.4)μmol/L。结论化合物1~16、18~24为首次从该植物中分离获得。发现部分化合物具有较好的体外抑制α-葡萄糖苷酶(18、19、24)和5-脂氧合酶(18、24)作用,表明其具有潜在的降血糖活性和抗炎活性。
Objective To study the chemical constituents from aerial part of Althaea officinalis and their inhibition activities in vitro towardα-glucosidase and 5-lipoxygenas.Methods Chemical constituents were separated and purified by column chromatography on D101 macroporous adsorption resin,silica gel,MCI gel,Sephadex LH-20,and semi-preparative RP-HPLC.The structures were characterized via spectroscopic data analysis.The inhibitory activities of the compounds againstα-glucosidase and 5-lipoxygenase in vitro were measured to evaluate its hypoglycemic and anti-inflammatory effects.Results Twenty-four compounds were isolated and identified as adenosine(1),leonuriside A(2),benzyl-O-β-D-glucopyranoside(3),meso-erythritol(4),5-hydroxymethyl2-furancarboxaldehyde(5),1-[5-(hydroxymethyl)furan-2-yl]ethenone(6),loliolide(7),isololiolide(8),4-hydroxybenzaldehyde(9),methyl 4-hydroxybenzoate(10),vomifoliol(11),(6S,7Z,9R)-roseoside(12),dihydrosyringenin(13),3-(3,4,5-trimethoxyphenyl)propan-1-ol(14),dihydrodehydrodiconifenyl alcohol(15),oleanolic acid 3-O-β-D-glucopyranoside(16),astragalin(17),trans-tiliroside(18),biondnoid I(19),apigenin 7-O-(6''-trans-p-coumaroyl-β-D-glucopyranoside)(20),diosmetin 7-O-β-Dglucopyranoside(21),tilianin(22),formononetin 7-glucoside(23),acacetin 7-O-(6''-p-coumaroyl)-β-D-glucopyranoside(24).The results of the bioactivity test showed that three of the 24 compounds(18,19,24)showed significant enzyme inhibitory activity againstα-glucosidase[IC50 values:(12.2±1.3)μmol/L,(2.8±0.6)μmol/L and(31.1±3.9)μmol/L]and two compounds(18,24)had significant enzyme inhibitory activity against 5-lipoxygenase with IC_(50) values of(34.76±4.3)μmol/L and(25.37±2.4)μmol/L.Conclusion Compounds 1—16,18—24 were isolated from A.officinalis for the first time.Furthermore,it was found that compounds have great inhibitory activities towardα-glucosidase(18,19,24)and 5-lipoxygenase(18,24),which show potential hypoglycemic activity and anti-inflammatory activity.
作者
薛涛涛
唐志书
段金廒
阮凯华
杨远贵
宋忠兴
许洪波
XUE Tao-tao;TANG Zhi-shu;DUAN Jin-ao;RUAN Kai-hua;YANG Yuan-gui;SONG Zhong-xing;XU Hong-bo(Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization,State Key Laboratory of Research and Development of Characteristic Resources of Qin Medicine,Shaanxi Institute of Traditional Chinese Medicine Industry,Shaanxi University of Chinese Medicine,Xianyang 712083,China;Collaborative Innovation Center of Chinese Medicinal Resources Industrialization of Jiangsu Province,Jiangsu Key Laboratory for Traditional Chinese Medical Formula Research,Nanjing University of Chinese Medicine,Nanjing 210023,China;Graduate School of China Academy of Chinese Medical Sciences,Beijing 100700,China)
出处
《中草药》
CAS
CSCD
北大核心
2023年第10期3060-3070,共11页
Chinese Traditional and Herbal Drugs
基金
陕西省科技统筹创新工程计划项目(2016KTTSSF01-06-01)
陕西省青年科技新星项目(2020KJXX-069)
现代农业产业技术体系建设专项基金项目(CARS-21)。